Savara Announces New U.S. Health Claims Data Analysis Finds Over 50% Increase in the Estimated Number of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) Patients Compared to Previous Claims ...
New dashboard helps U.S. property insurers navigate market shifts, benchmark claims performance, accelerate decision-making and address rising claim severities with greater confidence. ATLANTA, Sept.
Upwards of $2.1 billion has been requested by nearly 2,000 people who claim that they were abused as children while in state ...
Datavant, the data collaboration platform trusted for healthcare, today announced that it has signed an agreement to acquire ...
Claims data analysis of nearly 60 million people demonstrates that disease prevention and early intervention can cut Americans' health care costs and help safeguard Medicare for future generations. As ...
A new study in The Lancet Public Health notes changes in the new and total use of medications after shortage announcements in ...
Insurance companies operating in Texas closed almost half the claims filed by homeowners last year without paying anything, part of a rising trend that is shifting more costs onto property owners, ...
-- Approximately 5,500 Autoimmune PAP Patients in the U.S. Identified in the Updated Analysis that Leveraged a More Recent and Comprehensive Claims Data Source -- -- New England Journal of Medicine ...
Savara Inc. (the “Company”) (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced an increased estimate of autoimmune PAP diagnosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback